Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$158M |
| 2 |
Match Group
MTCH
|
+$112M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$62M |
| 4 |
Adobe
ADBE
|
+$51M |
| 5 |
KKR & Co
KKR
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$486M |
| 2 |
PPLI
People Inc
PPLI
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
Alibaba
BABA
|
+$109M |
| 5 |
Fastly Inc
FSLY
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
2526
DELISTED
IGM Biosciences
IGMS
| $87K | ﹤0.01% |
1,176
-306
| -21% | -$18.1K |
|
2527
Republic Bancorp
RBCAA
$1.95B
| $87K | ﹤0.01% |
3,113
-313
| -9% | -$9.64K |
|
2528
Veritone
VERI
$122M
| $87K | ﹤0.01% |
9,526
-899
| -9% | -$9.47K |
|
|
RESI
2529
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $87K | ﹤0.01% |
9,898
-18,598
| -65% | -$169K |
|
2530
EverQuote
EVER
$906M
| $86K | ﹤0.01% |
2,220
-582
| -21% | -$26.2K |
|
2531
Groupon
GRPN
$1.02B
| $85K | ﹤0.01% |
4,180
-9,506
| -69% | -$222K |
|
2532
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $85K | ﹤0.01% |
1,440
-420
| -23% | -$24.1K |
|
|
CLVS
2533
DELISTED
Clovis Oncology, Inc.
CLVS
| $85K | ﹤0.01% |
14,507
-1,976
| -12% | -$11.8K |
|
2534
Relmada Therapeutics
RLMD
$527M
| $84K | ﹤0.01% |
2,252
-583
| -21% | -$22.5K |
|
2535
Compugen
CGEN
$228M
| $83K | ﹤0.01% |
5,109
| – | – |
|
|
DVAX
2536
DELISTED
Dynavax Technologies
DVAX
| $83K | ﹤0.01% |
19,014
-2,076
| -10% | -$14.8K |
|
|
NVEE
2537
DELISTED
NV5 Global
NVEE
| $83K | ﹤0.01% |
6,272
-1,656
| -21% | -$22.1K |
|
2538
Utah Medical Products
UTMD
$225M
| $83K | ﹤0.01% |
1,037
-141
| -12% | -$11.7K |
|
|
KBAL
2539
DELISTED
Kimball International
KBAL
| $83K | ﹤0.01% |
7,822
-1,203
| -13% | -$13.4K |
|
|
AXDX
2540
DELISTED
Accelerate Diagnostics
AXDX
| $82K | ﹤0.01% |
765
-128
| -14% | -$17.8K |
|
2541
Great Southern Bancorp
GSBC
$878M
| $82K | ﹤0.01% |
2,278
-461
| -17% | -$17.4K |
|
2542
Silicon Motion
SIMO
$8.68B
| $82K | ﹤0.01% |
2,168
| – | – |
|
|
EIDX
2543
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $82K | ﹤0.01% |
1,622
-476
| -23% | -$21.4K |
|
2544
iHeartMedia
IHRT
$583M
| $81K | ﹤0.01% |
9,930
+214
| +2% | +$1.82K |
|
2545
First Financial Corp
THFF
$969M
| $81K | ﹤0.01% |
2,576
-538
| -17% | -$18.2K |
|
2546
Bank of Marin Bancorp
BMRC
$459M
| $80K | ﹤0.01% |
2,772
-460
| -14% | -$14.5K |
|
2547
BioXcel Therapeutics
BTAI
$27.8M
| $80K | ﹤0.01% |
115
-21
| -15% | -$15.8K |
|
2548
Miller Industries
MLR
$619M
| $80K | ﹤0.01% |
2,606
-379
| -13% | -$11.4K |
|
2549
StepStone Group
STEP
$3.82B
| $80K | ﹤0.01% |
+3,000
| New | +$76.5K |
|
|
ARCH
2550
DELISTED
Arch Resources, Inc.
ARCH
| $80K | ﹤0.01% |
1,891
-6,583
| -78% | -$234K |
|
Similar funds
Legal & General Group's Q3 2020 Portfolio in Review
As of Q3 2020, Legal & General Group held 3,476 positions worth $224B, up 8.1% from $207B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 3.2%. Legal & General Group opened 73 new positions and exited 39, leaving the 3,476-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Legal & General Group's largest Q3 2020 buy was AstraZeneca: 305,330 shares worth $33.5M.
- Legal & General Group added most to Zoom in Q3 2020, an estimated $158M increase.
- Legal & General Group's biggest Q3 2020 reduction was Apple, cutting an estimated $486M.
- Legal & General Group fully exited 58.com Inc in Q3 2020, selling an estimated $44.9M.
- Legal & General Group's ten largest holdings make up 22% of its $224B portfolio in Q3 2020.
- Legal & General Group opened 73 new positions and closed 39 in Q3 2020.
- Legal & General Group's portfolio value rose 8.1% quarter-over-quarter to $224B.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.